go back

Malignant Breast Disorders with Complications

North Dakota rates for MS-DRG 598

Malignant Breast Disorders with CC

Rates data updated July 2026.

How much does Malignant Breast Disorders with Complications cost?

$14,125

Typical facility fee. In North Dakota, July 2026.

Insurers have agreed to pay about $14,125 for this service. Most negotiated rates run $14,125 to $15,849.

Few insurers publish rates for this combination, so treat this figure as a rough guide.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 4 insurance carriers under federal price transparency rules.

How much rates vary

Facilitymedian $14,125 · 10th to 90th $8,318 to $19,498
$10K$20Kfacility $14,125

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$14,125.38
Median
$14,125.38
Typical High
$14,125.38
Cigna
Setting
Facility
Modifier
Global
Typical Low
$21,877.62
Median
$25,118.86
Typical High
$39,810.72
Medica
Setting
Facility
Modifier
Global
Typical Low
$8,128.31
Median
$8,317.64
Typical High
$19,498.45
United
Setting
Facility
Modifier
Global
Typical Low
$8,128.31
Median
$15,135.61
Typical High
$19,054.61

Where North Dakota sits

The same service costs 5.4 times more in Montana than in New Mexico. Every bar is a state, most expensive first. Touch or drag across it to read any state, then open that state for its carriers and full range.

North Dakota· 35th of 51

$14,125

MT $48,978NM $9,120

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.